The FDA has granted fast track designation to HLD-0915 for the treatment of metastatic castration-resistant prostate cancer.

Only patients who received rituximab, ipilimumab plus nivolumab, and trastuzumab plus pertuzumab had infusion-related reactions in the real-world cohort.

Subspecialization in oncology is increasing in the United States, but it varies across cancer types and regions, data suggest.

Both doctors and patients should pay attention to blood glucose monitoring and manage hyperglycemia,” the researchers wrote.

Two researchers describe their experiences with cancer research funding cuts due to the Trump administration’s policies and actions.

The ASPR must update its 2022 list of 86 essential medicines and provide a plan to store and maintain a 6-month supply of APIs for drugs on the updated list, the order states.

Fifty-four percent of Americans surveyed said they drink alcohol — the lowest rate Gallup has recorded in nearly 90 years of tracking.

The nationwide shortage of sodium chloride 0.9% intravenous saline has officially ended, according to the FDA.

Childhood cancer survivors with diabetes mellitus have an increased risk of neurocognitive impairment, a study suggests.

The mechanism we delineated … can be targeted at multiple levels with existing drugs, potentially improving disease outcomes in this patient population,” said Lorenzo Galluzzi, PhD.

Physician attire impacts patients' perceptions of professionalism, trust, and communication, but perceptions are highly context-dependent, research suggests.

The FDA has accepted for review the NDA for vepdegestrant to treat ESR1-mutated, ER+, HER2- advanced breast cancer.